Home > Result Summaries: Compounds > GSK221149 Result Summaries: GSK221149 GSKStudy ID Phase Title Summary (Download) 105036 Phase 1 A single-blind, randomized, placebo-controlled study to investigate the safety, tolerability, and potential effects on betamethasone pharmacokinetics of a co administered infusion of the new chemical entity (NCE) in healthy female subjects. (0 citation(s))
